12/25
06:10 am
coll
Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus [Yahoo! Finance]
Low
Report
Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus [Yahoo! Finance]
11/14
06:52 am
coll
Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest [Yahoo! Finance]
11/13
11:16 am
coll
Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? [Yahoo! Finance]
Neutral
Report
Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? [Yahoo! Finance]
11/12
08:00 am
coll
Collegium to Participate in Upcoming Investor Conferences
Medium
Report
Collegium to Participate in Upcoming Investor Conferences
11/9
08:42 am
coll
Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
11/8
10:19 am
coll
Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
Medium
Report
Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
11/8
09:58 am
coll
Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock? [Yahoo! Finance]
Low
Report
Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock? [Yahoo! Finance]
11/7
07:48 pm
coll
Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates [Yahoo! Finance]
High
Report
Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates [Yahoo! Finance]
11/7
04:18 pm
coll
Collegium Reports Record Third Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
Collegium Reports Record Third Quarter 2024 Financial Results [Yahoo! Finance]
11/7
04:02 pm
coll
Collegium Reports Record Third Quarter 2024 Financial Results
High
Report
Collegium Reports Record Third Quarter 2024 Financial Results
11/7
04:01 pm
coll
Collegium Appoints Vikram Karnani as Chief Executive Officer
Medium
Report
Collegium Appoints Vikram Karnani as Chief Executive Officer
11/6
07:41 am
coll
What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings [Yahoo! Finance]
Low
Report
What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings [Yahoo! Finance]
10/28
12:47 pm
coll
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards? [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards? [Yahoo! Finance]
10/28
11:40 am
coll
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? [Yahoo! Finance]
Low
Report
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? [Yahoo! Finance]
10/24
08:00 am
coll
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
Medium
Report
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
10/23
02:07 am
coll
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
10/15
11:04 pm
coll
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
10/11
03:01 pm
coll
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $37.00 price target on the stock.
Low
Report
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $37.00 price target on the stock.